相关产品推荐更多 >

NUDT1抗体NUDT1一抗抗体Nudt1 antibody抗体NUDT1 Antibody抗体
¥3900
GHRHR抗体GHRHR一抗抗体Growth hormone-releasing hormone receptor antibody抗体GHRHR Antibody抗体
¥880
CDK12抗体CDK12一抗抗体Pksc antibody抗体CDK12 Antibody抗体
¥1100
TREM2抗体TREM2一抗抗体Triggering receptor expressed on myeloid cells 2 antibody抗体TREM2 Antibody抗体
¥1100
RBPJ抗体RBPJ一抗抗体SUH_HUMAN antibody抗体RBPJ Antibody抗体
¥3900
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Zebrafish Actin, cytoplasmic 2 protein (2-375AA)
- 亚型:
IgG
- 形态:
Liquid
- 保存条件:
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性:
Polyclonal
- 标记物:
HRP
- 适应物种:
Zebrafish
- 保质期:
6个月
- 抗原来源:
Danio rerio (Zebrafish) (Brachydanio rerio)
- 目录编号:
Q7ZVF9
- 级别:
优
- 库存:
200
- 供应商:
武汉华美生物工程有限公司
- 宿主:
Rabbit
- 应用范围:
ELISA
- 浓度:
>95%,Protein G purified
- 靶点:
actbb
- 抗体英文名:
actbb Antibody, HRP conjugated
- 抗体名:
actbb antibody;bactin2Actin antibody;cytoplasmic 2 antibody;Beta-actin-2) [Cleaved into: Actin antibody;cytoplasmic 2 antibody;N-terminally processed] antibody
- 规格:
100μg/50μg
| 规格: | 100μg | 产品价格: | ¥1320.0 |
|---|---|---|---|
| 规格: | 50μg | 产品价格: | ¥880.0 |
保存缓冲液
Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
功能
Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Conjugation of Antibody to HRP
the first peak. Preparation of Ab:HRP Conjugate Immediately mix the HRP with the thiolated antibody at 1 mg HRP per mg antibody. Gently stir for 16-20 hours at 2-8oC. Dialyze against 3 changed of PBS, changing every 2 hours, 100X the conjugate
Conjugation of Antibody to HRP
the first peak. Preparation of Ab:HRP Conjugate Immediately mix the HRP with the thiolated antibody at 1 mg HRP per mg antibody. Gently stir for 16-20 hours at 2-8o C
双特异抗体(Bispecific antibody)的简介和制作方法
,inflammatory cytokines, chemotherapeutics or prodrugs. There is a growing number of approved cancer therapeutics that are efficacious either as chimerized antibody or humanized IgG1,or as conjugate with chemotherapeutics or a radioisotope. In spite
技术资料暂无技术资料 索取技术资料





